NICE approves twice-yearly infusion that ‘significantly outperforms’ usual treatments for severe lupus

Guidance says obinutuzumab, taken with daily immunosuppressant tablet mycophenolate mofetil, could benefit around 12,000 people in England.…
Published: 22 January 2026